Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stimulated CD4+ T lymphocytes can differentiate into effector T cell (Teff) or inducible regulatory T cell (Treg) subsets with specific immunological roles. We show that Teff and Treg require distinct metabolic programs to support these functions. Th1, Th2, and Th17 cells expressed high surface levels of the glucose transporter Glut1 and were highly glycolytic. Treg, in contrast, expressed low levels of Glut1 and had high lipid oxidation rates. Consistent with glycolysis and lipid oxidation promoting Teff and Treg, respectively, Teff were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation. Importantly, AMP-activated protein kinase stimulation was sufficient to decrease Glut1 and increase Treg generation in an asthma model. These data demonstrate that CD4+ T cell subsets require distinct metabolic programs that can be manipulated in vivo to control Treg and Teff development in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to Treg cells, TH2 cells were shown to display an increased glycolytic rate44.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“This increased mitochondrial metabolism in Tregs was found to be due to increased AMPK-dependent fatty acid oxidation (MacIver et al., 2011; Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [108]
In the citing paper
“Tregs have elevated levels of oxidative phosphorylation and decreased glycolytic flux compared to Th17 cells (Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
In the citing paper
“This was first demonstrated by Michalek et al. (34), who determined that proinflammatory CD4+ T helper (TH) cells (TH1, TH2, and TH17 lineages) displayed a strong bias toward glycolysis over mitochondrial metabolism, whereas induced CD4+ T regulatory (Treg) lineage cells displayed a mixed metabolism involving glycolysis, lipid oxidation, and OXPHOS.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“To meet these requirements, activated T cells decrease lipid oxidation and undergo a rapid increase in glycolysis (4).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2×
“At the conclusion of an immune response, decreased glycolysis and increased lipid oxidation can favor the enrichment of long-lived CD8 memory cells (5, 6).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 4×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodInfluentialThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 5×
“1G) and Ig deposition in the kidneys (3).”
BackgroundSelf-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“In contrast, the AMPK pathway acts to inhibit mTOR by suppressing mTOR signaling and to promote mitochondrial oxidative metabolism rather than glycolysis (10).”
BackgroundThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737 · cited 1×
“Inhibition of mTOR can result in the elevated oxidation of exogenous FA (15) and promote Treg differentiation (16).”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 1×
“stable pool of important immune regulatory cells (18), and lipid oxidation may be central in contributing to their maintenance and self-renewal.”
BackgroundWieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · cited 3×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodSelf-citation
Cited by
Items 501–600 of 1,005
PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia
Spaner, D., Lee, E., Shi, Y., Wen, F., Li, Y., Tung, S., McCaw, L., Wong, K. K. W., Gary‐Gouy, H., Dalloul, A. H., et al. (2012) · Leukemia · doi:10.1038/leu.2012.329 · Cited by 85
A Metabolism Toolbox for CAR T Therapy
Xu, X., Gnanaprakasam, J. N. R., Sherman, J., & Wang, R. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00322 · Cited by 83
Lymphocyte Activation Gene-3 Maintains Mitochondrial and Metabolic Quiescence in Naive CD4+ T Cells
Previte, D. M., Martins, C. P., O’Connor, E. C., Marre, M. L., Coudriet, G. M., Beck, N. W., Menk, A. V., Wright, R. H., Tse, H. M., Delgoffe, G. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.004 · Cited by 82
Ji, Y., Yang, C., Tang, Z., Yang, Y., Tian, Y., Yao, H., Zhu, X. D., Zhang, Z., Ji, J., & Zheng, X. (2017) · Nature Communications · doi:10.1038/ncomms15308 · Cited by 90
Lactate transporters as therapeutic targets in cancer and inflammatory diseases
Pucino, V., Cucchi, D., & Mauro, C. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1511706 · Cited by 90
The Warburg effect: molecular aspects and therapeutic possibilities
Ngo, H. G., Tortorella, S. M., Ververis, K., & Karagiannis, T. C. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3764-7 · Cited by 85
Qian, X., Aboushousha, R., van de Wetering, C., Chia, S. B., Amiel, E., Schneider, R. W., van der Velden, J. L. J., Lahue, K. G., Hoagland, D. A., Casey, D. T., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.043 · Cited by 88
mTOR and other effector kinase signals that impact T cell function and activity
Myers, D. R., Wheeler, B. D., & Roose, J. P. (2019) · Immunological Reviews · doi:10.1111/imr.12796 · Cited by 85
The emerging role of microbiota-derived short-chain fatty acids in immunometabolism
Jasim, S. A., Opulencia, M. J. C., Ramírez‐Coronel, A. A., Abdelbasset, W. K., Abed, M. H., Markov, A. A., Al‐Awsi, G. R. L., Shamsiev, J. A., Hammid, A. T., Shalaby, M. N., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108983 · Cited by 97
Interferon Regulatory Factor 4 controls TH1 cell effector function and metabolism
Mahnke, J., Schumacher, V., Ahrens, S., Käding, N., Feldhoff, L. M., Huber, M., Rupp, J., Raczkowski, F., & Mittrücker, H.-W. (2016) · Scientific Reports · doi:10.1038/srep35521 · Cited by 80
Fine tuning of immunometabolism for the treatment of rheumatic diseases
Rhoads, J. P., Major, A. S., & Rathmell, J. C. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.54 · Cited by 79
Self-citationFranchi, L., Monteleone, I., Hao, L.-Y., Spahr, M. A., Zhao, W., Liu, X., Demock, K. M., Kulkarni, A., Lesch, C. A., Sanchez, B., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600810 · Cited by 82
Regulators of Glucose Metabolism in CD4+ and CD8+ T Cells
Palmer, C. S., Hussain, T., Duette, G., Weller, T. J., Ostrowski, M., Sada‐Ovalle, I., & Crowe, S. M. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1082178 · Cited by 88
Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function
Poznanski, S. M., Barra, N. G., Ashkar, A. A., & Schertzer, J. D. (2018) · Inflammation Research · doi:10.1007/s00011-018-1174-3 · Cited by 83
Wu, D., Ding, Y., Yu, X., Ma, D., Yang, B., Li, Y., Huang, L., Chen, Z., Zheng, J., & Yang, C. (2019) · PubMed Central · Cited by 274
Shen, H., Ojo, O. A., Ding, H., Mullen, L. J., Xing, C., Hossain, M. I., Yassin, A., Shi, V. Y., Lewis, Z., Podgórska, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53593-8 · Cited by 101
“We therefore asked if anaerobic glycolysis of hypoxic T cells, under the regulation of HIF1 α , controls IFN-γ production 6,7,40 .”
Nicholas, D., Proctor, E. A., Raval, F., Ip, B. C., Habib, C., Ritou, E., Grammatopoulos, T. N., Steenkamp, D., Dooms, H., Apovian, C. M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170975 · Cited by 85
Cucchi, D., Camacho‐Muñoz, D., Certo, M., Pucino, V., Nicolaou, A., & Mauro, C. (2020) · Cell Stress · doi:10.15698/cst2020.01.209 · Cited by 83
“[49] have reported that Teff cells and Treg cells exhibit different metabolic requirements for differentiation and function, with the former being more glycolytic”
BackgroundZhao, D., Long, X., Lu, T., Wang, T., Zhang, W., Liu, Y., Cui, X., Dai, H., Xue, F., & Xia, Q. (2015) · International Journal of Cancer · doi:10.1002/ijc.29305 · Cited by 77
Fu, J., Shi, H., Wang, B., Zhan, T., Shao, Y., Ye, L., Wu, S., Yu, C., & Zheng, L. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102358 · Cited by 83
Calcium regulation of T cell metabolism
Wang, Y., Tao, A. Y., Vaeth, M., & Feske, S. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.07.016 · Cited by 82
Bustos, S. O., Antunes, F., Rangel, M. C., & Chammas, R. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.606436 · Cited by 82
Insulin and cancer: a tangled web
Leitner, B. P., Siebel, S., Akingbesote, N. D., Zhang, X., & Perry, R. J. (2022) · Biochemical Journal · doi:10.1042/bcj20210134 · Cited by 84
MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer
Casacuberta‐Serra, S., González-Larreategui, Í., Capitán-Leo, D., & Soucek, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01907-z · Cited by 100
Krupar, R., Robold, K., Gaag, D., Spanier, G., Kreutz, M., Renner, K., Hellerbrand, C., Hofstaedter, F., & Bosserhoff, A. K. (2014) · Virchows Archiv · doi:10.1007/s00428-014-1630-6 · Cited by 75
“Especially the dependence of Th17 T cells on the stimulating effects of lactic acid indicates decreased lactic acid supply in HPV-positive OPSCC [47, 48].”
BackgroundMartínez-Sánchez, M. E., Huerta, L., Alvarez-Buylla, E. R., & Villarreal, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00877 · Cited by 91
“For such transition, it is also necessary to alter the internal state of the cell, changing the expression levels of key transcription factors, as it has been shown in experimental studies (Michalek et al., 2011; Berod et al., 2014; Gagliani et al., 2015).”
BackgroundPacella, I., & Piconese, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01889 · Cited by 83
AlZaim, I., Hammoud, S. H., Al-Koussa, H., Ghazi, A., Eid, A. H., & El-Yazbi, A. F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.602088 · Cited by 73
Xu, C., Feng, C., Huang, P., Li, Y., Liu, R., Liu, C., Han, Y., Chen, L., Ding, Y., Shao, C., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03178-3 · Cited by 86
Wang, Y., Li, J., Nakahata, S., & Iha, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137346 · Cited by 98
“Etomoxir, by pharmacologically inhibiting CPT-1, affects FAO, leading to reduced Treg proliferation [104].”
BackgroundImmunometabolism of AMPK in insulin resistance and atherosclerosis
Fullerton, M. D., Steinberg, G. R., & Schertzer, J. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.004 · Cited by 77
Treg programming and therapeutic reprogramming in cancer
Ayala, M. A. M., Li, Z., & DuPage, M. J. P. (2019) · Immunology · doi:10.1111/imm.13058 · Cited by 79
Targeting immune cell metabolism in kidney diseases
Basso, P. J., Andrade‐Oliveira, V., & Câmara, N. O. S. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00413-7 · Cited by 80
Circadian Clock Regulates Inflammation and the Development of Neurodegeneration
Wang, X., & Li, L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.696554 · Cited by 84
Lipid Droplets, the Central Hub Integrating Cell Metabolism and the Immune System
Zhang, W., Xu, L., Zhu, L., Liu, Y., Yang, S., & Zhao, M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.746749 · Cited by 81
“The difference is that the levels of glycolysis in Treg cells are relatively low, and fatty acid oxidation provides the primary fuel (Michalek et al., 2011).”
BackgroundInfluentialExhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
McRitchie, B., & Akkaya, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940052 · Cited by 83
Henschel, P., Landwehr-Kenzel, S., Engels, N., Schienke, A., Kremer, J., Riët, T., Redel, N., Iordanidis, K., Saetzler, V., John, K., et al. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103057 · Cited by 81
Lü, S., Deng, J., Liu, H., Liu, B., Yang, J., Miao, Y., Li, J., Wang, N., Jiang, C., Xu, Q., et al. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1645-6 · Cited by 77
Fatty Acid Oxidation in Cell Fate Determination
Xiong, J. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.04.006 · Cited by 78
Metabolic heterogeneity and adaptability in brain tumors
Badr, C. E., Silver, D. J., Siebzehnrübl, F. A., & Deleyrolle, L. P. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03569-w · Cited by 78
Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?
Sena, L. A., & Denmeade, S. R. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1392 · Cited by 81
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function
Nicolaou, A., Mauro, C., Urquhart, P., & Marelli‐Berg, F. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00075 · Cited by 88
Priyadharshini, B., Loschi, M., Newton, R. H., Zhang, J.-W., Finn, K. K., Gerriets, V. A., Huynh, A., Rathmell, J. C., Blazar, B. R., & Turka, L. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800311 · Cited by 73
“For differentiated cells analyzed at day 5, cells were split 1:2 on day 3 and rested with IL-2 100 IU/ml for 48 h before analysis as described previously (10).”
MethodSelf-citationMitochondrial Dysfunction and Immune Cell Metabolism in Sepsis
Park, D. W., & Zmijewski, J. W. (2017) · Infection and Chemotherapy · doi:10.3947/ic.2017.49.1.10 · Cited by 81
“Activated T helper cells use glycolysis to support their effector functions [104], whereas Treg cell predominantly use OxPhos and mitochondrial FAO for development and survival [105].”
BackgroundThe Immune Consequences of Lactate in the Tumor Microenvironment
Harmon, C., O’Farrelly, C., & Robinson, M. W. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_7 · Cited by 78
“…together with increased fatty acid oxidation, which reduces intracellular lipid accumulation, are associated with suppressive immune responses, the generation of immune tolerance, and the promotion of memory cell generation and survival (Yaqoob, 2003; Pearce et al., 2009; Michalek et al., 2011).”
BackgroundWang, X., Wei, Y., Hu, B., Liao, Y., Wan, W., Wan, W., Huang, C.-X., Mahabati, M., Liu, Z., Qu, J.-R., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00948-6 · Cited by 76
Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy
Feng, Y., Tang, Q., Wang, B., Yang, Q., Zhang, Y., Lei, L., & Li, S. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03005-2 · Cited by 83
“Tregs, characterized by a high FOXP3, CD25, and CD4 expression, frequently accumulate in tumors [31].”
Metabolic checkpoints in immune cell reprogramming: rewiring immunometabolism for cancer therapy
Lv, Y., Li, Z., Liu, S., Zhou, Z., Jinling, S., Ba, Y., Weng, S., Zuo, A., Xu, H. W., Luo, P., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02407-6 · Cited by 98
Mechanistic roles of autophagy in hematopoietic differentiation
Riffelmacher, T., & Simon, A. (2017) · The FEBS Journal · doi:10.1111/febs.13962 · Cited by 71
Mitochondria: A master regulator in macrophage and T cell immunity
Liu, P.-S., & Ho, P. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.11.002 · Cited by 74
Ullah, U., Andrabi, S. B. A., Tripathi, S. K., Dirasantha, O., Kanduri, K., Rautio, S., Groß, C. C., Lehtimäki, S., Bala, K., Tuomisto, J. E. E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.070 · Cited by 75
“Several glycolytic enzymes, including glucokinase (GCK), the enzyme required for the first step of glycolysis, were significantly downregulated in HIC1-deficient cells (Table S3), suggesting that these cells lost the ‘‘iTreg type’’ metabolic profile given that Treg cells preferentially use glycolysis as a source of en…”
BackgroundPereira, F. V., de Melo, A. C. L., Low, J. S., de Castro, Í. A., Braga, T. T., de Almeida, D. C., de Lima, A. G. U. B., Hiyane, M. I., Corrêa-Costa, M., Andrade‐Oliveira, V., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25380 · Cited by 82
Salzberger, W., Martrus, G., Bachmann, K., Goebels, H., Heß, L., Koch, M., Langeneckert, A., Lunemann, S., Oldhafer, K. J., Pfeifer, C., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0201170 · Cited by 71
Role of purines in regulation of metabolic reprogramming
Tang, Z., Ye, W., Chen, H., Kuang, X., Guo, J., Xiang, M., Peng, C., Chen, X., & Liu, H. (2019) · Purinergic Signalling · doi:10.1007/s11302-019-09676-z · Cited by 79
“Glucose depletion has a profound impact on the function of surrounding immune cells by favoring the growth and differentiation of Tregs, which have higher AMPK activity, lower glucose oxidation, and greater fatty acid oxidation to support energy homeostasis [151, 154, 155].”
BackgroundHurley, H. J., Dewald, H. K., Rothkopf, Z. S., Singh, S., Jenkins, F., Deb, P. Q., De, S., Barnes, B. J., & Fitzgerald-Bocarsly, P. A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi0220-130 · Cited by 79
Xu, R., Wu, M., Liu, S., Shang, W., Li, R., Xu, J., Huang, L., & Wang, F. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03272-5 · Cited by 77
Regulatory T cells as metabolic sensors
de Candia, P., Procaccini, C., Russo, C., Lepore, M. T., & Matarese, G. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.006 · Cited by 72
Slaninová, V., Krafčíková, M., Pérez-Gómez, R., Steffal, P., Trantírek, L., Bray, S. J., & Krejčí, A. (2016) · Open Biology · doi:10.1098/rsob.150155 · Cited by 74
Glycolysis Inhibition Induces Functional and Metabolic Exhaustion of CD4+ T Cells in Type 1 Diabetes
Martins, C. P., New, L. A., O’Connor, E. C., Previte, D. M., Cargill, K. R., Tse, I., Sims‐Lucas, S., & Piganelli, J. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669456 · Cited by 78
Jia, M., Wang, Y., Wang, J., Qin, D., Wang, M., Chai, L., Fu, Y., Zhao, C., Gao, C., Jia, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36332-3 · Cited by 77
Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Zhou, Y., Yuan, J. T., Xu, K., Li, S., & Liu, Y. (2024) · ACS Nano · doi:10.1021/acsnano.3c11260 · Cited by 79
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Stroope, C., Nettersheim, F. S., Coon, B. G., Finney, A. C., Schwartz, M. A., Ley, K. F., Rom, O., & Yurdagul, A. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01015-w · Cited by 77
The effects of age and systemic metabolism on anti-tumor T cell responses
Drijvers, J. M., Sharpe, A. H., & Haigis, M. C. (2020) · eLife · doi:10.7554/elife.62420 · Cited by 69
“…metabolism is sufficient to change the differentiation of T cells toward distinct phenotypes, indicating that certain metabolic pathways lie upstream of fate decisions in T cells (Buck et al., 2016; Michalek et al., 2011; Pearce et al., 2009; Pollizzi et al., 2016; Verbist et al., 2016).”
BackgroundInfluentialMetabolic Pathways in Kidney Cancer: Current Therapies and Future Directions
Rathmell, W. K., Rathmell, J. C., & Linehan, W. M. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2309 · Cited by 74
Self-citationEpigenetic and metabolic programming of innate immunity in sepsis
Vachharajani, V., & McCall, C. E. (2019) · Innate Immunity · doi:10.1177/1753425919842320 · Cited by 78
RETRACTED: Glutamine Metabolism and Its Role in Immunity, a Comprehensive Review
Shah, A. M., Wang, Z., & Ma, J. (2020) · Animals · doi:10.3390/ani10020326 · Cited by 76
“The current metabolic process takes part in the differentiation of CD4 as well as in T cell subunits, as mTOR-deprived mice show reduced differentiation for effector T lymphocytes [66,67].”
BackgroundRetractedMannose Treatment: A Promising Novel Strategy to Suppress Inflammation
Zhang, W., Cheng, H., Gui, Y., Zhan, Q., Li, S., Qiao, W., & Tong, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.756920 · Cited by 74
Lipid-loaded macrophages as new therapeutic target in cancer
Marelli, G., Morina, N., Portale, F., Pandini, M., Iovino, M., Di Conza, G., Ho, P.-C., & Di Mitri, D. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004584 · Cited by 69
“58 59 In particular conditions, such as hypoxia, Tregs can rely on free fatty acids (FFAs) as a major substrate for OXPHOS.”
BackgroundHarnessing FOXP3+ regulatory T cells for transplantation tolerance
Waldmann, H., Hilbrands, R., Howie, D., & Cobbold, S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67226 · Cited by 69
“In contrast to Th1, Th2, and Th17 cells, which have high plasma membrane expression of the GLUT1 glucose transporter and actively engage glycolysis, Tregs have little GLUT1 and use oxidative phosphorylation via lipid oxidation as their primary energy source (64, 65).”
Machacek, M. E., Saunders, H. I., Zhang, Z., Tan, E. P., Li, J., Li, T., Villar, M. T., Artigues, A., Lydic, T. A., Cork, G. K., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008373 · Cited by 71
The Tumor Microenvironment in Colorectal Cancer Therapy
Pedrosa, L., Esposito, F., Thomson, T. M., & Maurel, J. (2019) · Cancers · doi:10.3390/cancers11081172 · Cited by 69
Ubiquitin‐dependent regulation of Foxp3 and Treg function
Barbi, J. J., Pardoll, D. M., & Pan, F. (2015) · Immunological Reviews · doi:10.1111/imr.12312 · Cited by 68
“Indeed, the metabolic programming accomplished by HIF1 in effector T-cell differentiation may be wholly incompatible with the preferred lipid oxidation dominated metabolism of Tregs (125).”
BackgroundNeitzel, C., Demuth, P., Wittmann, S., & Fahrer, J. (2020) · Cancers · doi:10.3390/cancers12071731 · Cited by 76
Metabolic heterogeneity in cancer: An overview and therapeutic implications
Yu, T., Gao, W., & Liu, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188421 · Cited by 77
Howard, E. D., Lewis, G. M., Galle-Treger, L., Hurrell, B. P., Helou, D. G., Shafiei-Jahani, P., Painter, J. D., Muench, G. A., Soroosh, P., & Akbari, O. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.08.024 · Cited by 74
Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer
Kurniawan, H., Soriano‐Baguet, L., & Brenner, D. (2020) · European Journal of Immunology · doi:10.1002/eji.201948470 · Cited by 75
Therapeutic potential of interleukin-2 in autoimmune diseases
Yuan, Y., Kolios, A. G. A., Liu, Y., Zhang, B., Li, H., Tsokos, G. C., & Zhang, X. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.04.010 · Cited by 72
The relationship between CD4+ T cell glycolysis and their functions
Liu, S., Liao, S., Liang, L., Deng, J., & Zhou, Y. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.03.006 · Cited by 71
Understanding glycosylation: Regulation through the metabolic flux of precursor pathways
Scheper, A. F., Schofield, J., Bohara, R. A., Ritter, T., & Pandit, A. S. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108184 · Cited by 73
Hua, Y., Yang, S., Zhang, Y., Li, J., Wang, M., Yeerkenbieke, P., Liao, Q., & Liu, Q. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02925-5 · Cited by 77
“Within the intricate milieu of the tumor microenvironment, Tregs play a pivotal role in modulating immune responses, predominantly deriving their energy from fatty acid oxidation [55].”
BackgroundT cell metabolic reprogramming and plasticity
Slack, M., Wang, T., & Wang, R. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.036 · Cited by 68
“Consistent with the crucial role of mTORC1 in regulating T effector development and metabolism, the expression of HIF1α is also dependent on the function of mTORC1 during TH17 differentiation[20, 28, 31, 32].”
BackgroundInfluentialCellular Metabolism on T-Cell Development and Function
Chen, H., Yang, T., Zhu, L., & Zhao, Y. X. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.902452 · Cited by 75
“Decreased Glut1 expression by AMPK stimulation could increase CD4+CD25+ Treg cell generation dependently on lipid oxidation in an asthma model [49].”
BackgroundInfluentialStable human regulatory T cells switch to glycolysis following TNF receptor 2 costimulation
de Kivit, S., Mensink, M., Hoekstra, A. T., Berlin, I., Derks, R. J. E., Both, D., Aslam, M. A., Amsen, D., Berkers, C. R., & Borst, J. G. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00271-w · Cited by 72
Immunoengineering strategies to enhance vascularization and tissue regeneration
Zárubová, J., Hasani‐Sadrabadi, M. M., Ardehali, R., & Li, S. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114233 · Cited by 79
Metabolism and autophagy in the immune system: immunometabolism comes of age
Rathmell, J. C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01158.x · Cited by 77
“For example, addition of lipids increased Treg generation by fueling lipid oxidation, whereas overexpression of Glut1 to increase glucose uptake can increase effector T-cell proliferation (47, 89).”
BackgroundInfluentialSelf-citationMemory T cells in organ transplantation: progress and challenges
Espinosa, J. R., Samy, K. P., & Kirk, A. D. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.9 · Cited by 77
Nutrients and the microenvironment to feed a T cell army
Johnson, M. O., Siska, P. J., Contreras, D. C., & Rathmell, J. C. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.09.003 · Cited by 67
Self-citationAntitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy
Rivadeneira, D. B., & Delgoffe, G. M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0894 · Cited by 67
“These differential metabolic requirements of Tregs allow them to thrive in the tumor microenvironment and suppresses the antitumor immune response (40, 41).”
BackgroundEffector T cell differentiation: are master regulators of effector T cells still the masters?
Wang, C., Collins, M. A., & Kuchroo, V. K. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.08.001 · Cited by 75
Joffin, N., Paschoal, V. A., Gliniak, C. M., Crewe, C., Elnwasany, A., Szweda, L. I., Zhang, Q., Hepler, C., Kusminski, C. M., Gordillo, R., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.01.002 · Cited by 65
Adaptive immunity at the crossroads of autophagy and metabolism
Metur, S. P., & Klionsky, D. J. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00662-3 · Cited by 70
Umar, S., Palasiewicz, K., Volin, M. V., Romay, B., Rahat, R., Tetali, C., Arami, S., Gumá, M., Ascoli, C., Sweiss, N., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03978-5 · Cited by 71
Radiotherapy-induced metabolic hallmarks in the tumor microenvironment
Mittal, A., Nenwani, M., Sarangi, I., Achreja, A., Lawrence, T. S., & Nagrath, D. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.05.005 · Cited by 84
Intracellular metabolic pathways control immune tolerance
Procaccini, C., Galgani, M., Rosa, V. D., & Matarese, G. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.09.002 · Cited by 69
Regulatory T cells in acute and chronic kidney diseases
Sharma, R., & Kinsey, G. R. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00236.2017 · Cited by 69
Tian, Y., Chen, T., Wu, Y., Yang, L., Wang, L., Fan, X., Zhang, W., Feng, J., Yu, H., Yang, Y., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0623-6 · Cited by 66
“PIO rebalancesTh17/Treg by AMPK activation Activation of AMPK has been known to suppress inflammation [21], and is related to increased Treg in inflammatory diseases [30].”
BackgroundRegulatory T Cell Stability and Plasticity in Atherosclerosis
Ali, A. J., Makings, J., & Ley, K. (2020) · Cells · doi:10.3390/cells9122665 · Cited by 65
“Unlike Tcons, Tregs prefer OXPHOS and FAO to glycolysis [88].”
BackgroundBuicu, A., Cernea, S., Benedek, I., Buicu, C.-F., & Benedek, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081545 · Cited by 73
“Increased glycolysis fuels inflammation through various molecular mechanisms, such as signaling modulation, post-transcriptional and post-translational modification, epigenetic regulation, that trigger the expression of proinflammatory gene expression and cytokines secretion [99].”
BackgroundSkartsis, N., Peng, Y., Ferreira, L. M. R., Nguyen, V. Q., Ronin, É., Müller, Y. D., Vincenti, F. G., & Tang, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783282 · Cited by 76
Thioredoxin is a metabolic rheostat controlling regulatory B cells
Bradford, H. F., McDonnell, T. C. R., Stewart, A., Skelton, A. J., Ng, J. C.-F., Baig, Z., Fraternali, F., Dunn‐Walters, D. K., Isenberg, D. A., Khan, A. R., et al. (2024) · Nature Immunology · doi:10.1038/s41590-024-01798-w · Cited by 77
“These findings match the metabolic requirements of other immunoregulatory cell subsets including regulatory T cells and M2 macrophages 30,31 , suggesting a common role for OXPHOS in driving the differentiation of suppressive immune cell subsets.”
Metadata
- Authors
- Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 186
- Issue
- 6
- Pages
- 3299-3303
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3198034
- OpenAlex
- W2157739158
- Cited by
- 2,091
- References
- 18
- Citations by year
- 2026: 116 · 2025: 133 · 2024: 168 · 2023: 163 · 2022: 214 · 2021: 215 · 2020: 209 · 2019: 167 · 2018: 147 · 2017: 164 · 2016: 122 · 2015: 88 · 2014: 69 · 2013: 55 · 2012: 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Research Institute
- Lupus Research Institute
- Leukemia and Lymphoma Society
- American Asthma Foundation
- Lupus Research Alliance
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL108006)
- National Institute of Allergy and Infectious Diseases (R01AI063345)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- effector T cells, regulatory T cells, glycolysis, lipid oxidation, glucose transporter 1, AMPK, Th1 cells, Th2 cells, Th17 cells, asthma, Treg generation, inflammatory diseases
- MeSH terms
- Animals, Asthma, Cell Survival, Cells, Cultured, Disease Models, Animal, Glycolysis, T-Lymphocytes, Helper-Inducer, Mice, Inbred C57BL, Mice, Transgenic, Lipid Peroxidation, Immunophenotyping, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Glucose Transporter Type 1, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.